BPGbio Reports Encouraging Preliminary Data from Ongoing Phase 2 Study of BPM31510 in Newly Diagnosed Glioblastoma

Phase 2 findings presented at ASCO 2026 showed strong median overall survival of 19.3 months in evaluable patients, led by 29.3 months in MGMT ...

SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma

SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced ...
Business Wire

CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM) in China Based on Interim Analysis of Independent Data Monitoring Committee

BEIJING & BURLINGTON, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and ...
Medical Xpress

The battle against glioblastoma: Classifying molecular profiles for precision medicine

Glioblastoma multiforme (GBM) stands as a formidable adversary in oncology, characterized by its molecular complexity and relentless progression. Despite advancements, the high degree of tumor ...
Medical Xpress

Researchers report encouraging Phase 1 data for glioblastoma treatment

Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92% of evaluable patients treated with ...

Folded Hills Launches Grapes for Glioblastoma, a New Nonprofit Providing Direct Financial Relief to Brain Cancer Patients and Families

Folded Hills Winery, Ranch & Farmstead co-founders Kim and Andy Busch announce the official launch of Grapes for Glioblastoma ...
Nature

Treatment Modalities for Glioblastoma Multiforme

Glioblastoma multiforme (GBM) remains the most aggressive primary brain tumour in adults, characterised by rapid proliferation, diffuse infiltration and resistance to conventional therapies. Current ...
ascopubs.org

Integrating ayurveda rasayana therapy with standard of care therapies in patients with glioblastoma multiforme improves caregivers' quality of life: A prospective study.

Affecting burden and cost of care for the caregiver of dependent patients with advanced stage of cancer who had an arrangement for expected death at home. This is an ASCO Meeting Abstract from the ...
STAT

Small studies offer hope CAR-T can fight an aggressive brain cancer

A series of new studies are raising hopes that CAR-T, a process in which treatments are made by genetically editing a patient’s own white blood cells, can eventually be used to treat an incurable and ...
Business Wire

Lantern Pharma's Subsidiary, Starlight Therapeutics, Announces U.S. Food and Drug Administration Clearance of IND for Phase Ib/2a Glioblastoma Multiforme (GBM) Trial

Novel combination therapy with STAR-001 targets the most aggressive and deadliest forms of brain cancer at first progression GBM represents an annual market opportunity of $3 to $5 billion USD with an ...